Xcell Therapeutics Inc. (KOSDAQ:373110)
South Korea
· Delayed Price · Currency is KRW 3,170.00
-45.00 (-1.40%)
Jun 27, 2025, 3:30 PM KST
Xcell Therapeutics Revenue
Xcell Therapeutics had revenue of 329.78M KRW in the quarter ending March 31, 2025, a decrease of -36.79%. This brings the company's revenue in the last twelve months to 1.74B, up 16.01% year-over-year. In the year 2024, Xcell Therapeutics had annual revenue of 1.93B with 72.11% growth.
Revenue (ttm)
1.74B
Revenue Growth
+16.01%
P/S Ratio
20.09
Revenue / Employee
26.01M
Employees
67
Market Cap
35.00B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 4,898.69B |
| Celltrion | 3,662.23B |
| ALTEOGEN | 151.65B |
| Yuhan | 2,114.76B |
| SK Biopharmaceuticals | 578.00B |
| HLB Co., Ltd. | 74.64B |
| PharmaResearch | 392.31B |
| Peptron | 4.30B |